How many is enough? Will conjugated pneumococcal vaccines with more serotypes and fewer doses work better?

Journal of the Formosan Medical Association

Volumn 110, Issue 2, 2011, Pages 67-69

  Lu, Chun Yi ^a   Huang, Li Min ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PNEUMOCOCCUS VACCINE;

ANTIBIOTIC RESISTANCE; COST BENEFIT ANALYSIS; DRUG EFFICACY; HUMAN; IMMUNITY; INCIDENCE; LOBAR PNEUMONIA; NOTE; PREVALENCE; SEROTYPE; STREPTOCOCCUS PNEUMONIA; VACCINATION; WORLD HEALTH ORGANIZATION;

EID: 79955584342     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/S0929-6646(11)60011-9     Document Type: Note

References (10)

1. Wu PS, Huang LM, Chang IS, et al. The epidemiology of hospitalized children with pneumococcal/lobar pneumonia and empyema from 1997 to 2004 in Taiwan. Eur J Pediatr 2010;169:861-6.
2. Liao WH, Lin SH, Lai CC, et al. Impact of pneumococcal vaccines on invasive pneumococcal disease in Taiwan. Eur J Clin Microbiol Infect Dis 2010;29:489-92.
3. Lauderdale TL, Wagener MM, Lin HM, et al. Serotype and antimicrobial resistance patterns of Streptococcus pneumoniae isolated from Taiwanese children: comparison of nasopharyngeal and clinical isolates. Diagn Microbiol Infect Dis 2006;56:421-6.
4. Hsieh YC, Lin PY, Chiu CH, et al. National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: emergence of serotype 19A with high invasive potential. Vaccine 2009;27:5513-8.
5. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 2000; 19:187-95.
6. Hansen J, Black S, Shinefield H, et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs. Pediatr Infect Dis J 2006;25:779-81.
7. Sinha A, Levine O, Knoll MD, et al. Cost-effectiveness of pneumococcal conjugate vaccination in the prevention of child mortality: an international economic analysis. Lancet 2007;369:389-96.
8. Wisloff T, Abrahamsen TG, Bergsaker MA, et al. Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program. Vaccine 2006;24:5690-9.
9. Vestrheim DF, Hoiby EA, Bergsaker MR, et al. Indirect effect of conjugate pneumococcal vaccination in a 2 + 1 dose schedule. Vaccine 2010;28:2214-21.
10. Resti M, Moriondo M, Cortimiglia M, et al. Communityacquired bacteremic pneumococcal pneumonia in children: diagnosis and serotyping by real-time polymerase chain reaction using blood samples. Clin Infect Dis 2010;51:1042-9.